Literature DB >> 2470117

Loratadine, an antihistamine, blocks antigen-and ionophore-induced leukotriene release from human lung in vitro.

D M Temple1, M McCluskey.   

Abstract

Some H1-antihistamines possess anti-allergic properties, and inhibit the immunological release of mediators including histamine and sulfiopeptide-leukotrienes (slow reacting substance of anaphylaxis) from lung. The effects of the antihistiamine loratadine, SCH29851, on the release of leukotrienes and histamine from human lung fragments were measured, using the calcium ionophore A23187 and an extract of antigen from Dermatophagoides pteronyssinus, house dust mite, (with passively sensitized lung) as releasing agents. Loratadine (1-20 microM) inhibited the release of leukotrienes in a concentration-dependent manner when release was induced by calcium ionophore from lung specimens from 8 subjects, and also when release was induced by antigen from lung specimens from 7 subjects. Histamine release was unaffected by these concentrations of loratadine in both types of experiment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2470117     DOI: 10.1016/0090-6980(88)90030-5

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  8 in total

Review 1.  New insights into the second generation antihistamines.

Authors:  G M Walsh; L Annunziato; N Frossard; K Knol; S Levander; J M Nicolas; M Taglialatela; M D Tharp; J P Tillement; H Timmerman
Journal:  Drugs       Date:  2001       Impact factor: 9.546

2.  The effect of cetirizine and loratadine on codeine-induced histamine release in human skin in vivo assessed by cutaneous microdialysis.

Authors:  M Perzanowska; D Malhotra; S P Skinner; J P Rihoux; A P Bewley; L J Petersen; M K Church
Journal:  Inflamm Res       Date:  1996-09       Impact factor: 4.575

Review 3.  [Rational symptomatic therapy for chronic pruritus].

Authors:  S Ständer
Journal:  Hautarzt       Date:  2006-05       Impact factor: 0.751

Review 4.  Loratadine. A review of recent findings in pharmacology, pharmacokinetics, efficacy, and safety, with a look at its use in combination with pseudoephedrine.

Authors:  I J Roman; M R Danzig
Journal:  Clin Rev Allergy       Date:  1993

5.  [Antipruritic efficacy of a high-dosage antihistamine therapy. Results of a retrospectively analysed case series].

Authors:  S Schulz; M Metz; D Siepmann; T A Luger; M Maurer; S Ständer
Journal:  Hautarzt       Date:  2009-07       Impact factor: 0.751

Review 6.  Urticaria. Recognition, causes and treatment.

Authors:  A D Ormerod
Journal:  Drugs       Date:  1994-11       Impact factor: 9.546

Review 7.  Loratadine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  S P Clissold; E M Sorkin; K L Goa
Journal:  Drugs       Date:  1989-01       Impact factor: 9.546

Review 8.  Loratadine. A reappraisal of its pharmacological properties and therapeutic use in allergic disorders.

Authors:  M Haria; A Fitton; D H Peters
Journal:  Drugs       Date:  1994-10       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.